PMPC Organises Three Pediatric Sessions at PMNET Forum 2026
The fifth international PMNET Forum took place in Riga on 8–9 October 2026, bringing together clinicians, researchers and experts from Latvia and abroad to discuss advances in precision medicine. For the second consecutive year, the Centre of Excellence for Precision Medicine in Pediatric Care (PMPC) organised the Forum’s pediatric sessions, focusing on emerging opportunities in the diagnosis and treatment of childhood diseases.
The fifth international PMNET Forum took place in Riga on 8–9 October 2026, bringing together clinicians, researchers and experts from Latvia and abroad to discuss advances in precision medicine. For the second consecutive year, the Centre of Excellence for Precision Medicine in Pediatric Care (PMPC) organised the Forum’s pediatric sessions, focusing on emerging opportunities in the diagnosis and treatment of childhood diseases.
On the first day of the Forum, PMPC organised three sessions covering rapid molecular diagnostics, rare diseases and CAR-T therapies. Local and international experts shared their research, clinical experience and perspectives on how precision medicine can advance pediatric care.
Rapid Molecular Diagnostics
The Rapid Molecular Diagnostics session explored emerging molecular diagnostic methods that can help characterise diseases more precisely and support faster clinical decision-making. Topics included whole-genome sequencing for central nervous system tumour diagnostics, the use of artificial intelligence to predict tumour molecular subtypes, and the potential of long-read sequencing in rare disease diagnosis.
The session was chaired by Dr. Egija Berga-Švītiņa, geneticist at Children’s Clinical University Hospital, and Dr. Lennart Kester, Associate Group Leader at the Princess Máxima Center in the Netherlands. Speakers also included experts from Oslo University Hospital in Norway, the Hopp Children’s Cancer Center Heidelberg and the German Cancer Research Center in Germany, and Children’s Mercy Research Institute in the USA.
Rare Diseases
The Rare Diseases session focused on the role of precision medicine in diagnosing rare conditions and improving patient care. Discussions covered genomic and epigenomic analyses, chronic pain management, and opportunities to improve the patient journey from diagnosis to long-term care.
The session was chaired by Dr. Madara Auzenbaha, rare disease doctor at Children’s Clinical University Hospital, and Dr. Lina Jankauskaitė from the Lithuanian University of Health Sciences. Experts from Latvia and Lithuania shared their research and perspectives on developing more personalised approaches to rare disease care.
CAR-T Therapies
The CAR-T Therapies session explored advances in cell therapy and its potential to expand treatment options for children. Discussions addressed the application of CAR-T therapy beyond malignant haematological diseases, as well as the development and clinical translation of new cell and gene therapies.
The session was chaired by PMPC Leading Researcher Dr. Mirjam Blattner-Johnson and Dr. Una Riekstiņa from Children’s Clinical University Hospital. Speakers represented the Lithuanian University of Health Sciences, Tartu University Hospital and Icosagen Cell Factory in Estonia, as well as the Princess Máxima Center in the Netherlands. A patient story added an important personal perspective, highlighting the impact that innovative treatments can have on the lives of those who need them.
Participation in PMNET Forum provided the PMPC team with an opportunity to strengthen international connections, learn about emerging research and foster dialogue between clinicians and researchers. Such knowledge exchange is essential for translating scientific discoveries and technological advances into clinical practice.
PMPC’s mission is to advance precision medicine in pediatric care, supporting more accurate diagnosis and personalised treatment for children with rare, complex and oncological diseases. International partnerships and the exchange of expertise remain important to achieving this goal.











